Iridex

IRIXNasdaq United States Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market cap

$11.163 M

$0.64 -1.17%

Close of 22 Sept 2026

Revenue

$52.7M

#2716 by revenue

Earnings

-$4.44M

Loss-making

Shares outstanding

17,564,912

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Electromedical & Electrotherapeutic Apparatus, ranked by market cap

All 28 →

#22Qt ImagingQTI$38.1M
#23iTonicITOC$37.5M
#24IridexIRIX$11.2M
#25ENDRA Life SciencesNDRA$9.34M
#26Nexalin TechnologyNXL$3.84M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of Iridex, worth $1.53K. Grants and option exercises are excluded.

Romeo R. DizonChief Financial Officer$1.53K
2,354 shares at $0.65 on 14 Sept 2026 · filed 14 Sept 2026

What if Iridex were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,721,271

Per share 2,708,530× higher

Bitcoin $1.74T

$99,155.35

Per share 156,027× higher

Nvidia $5.52T

$314,021.89

Per share 494,134× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for Iridex are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.